子宫平滑肌肉瘤:MRI能否在治疗前将平滑肌肉瘤与良性平滑肌瘤区分开来
本文阐述子宫平滑肌瘤的流行病学、临床和经济影响,总结治疗潜在隐匿性平滑肌肉瘤患者的担忧,并综述典型与非典型平滑肌瘤的已知和新兴影像特征及其与平滑肌肉瘤的鉴别方法。结论指出,美国FDA审查发现因推定良性平滑肌瘤行子宫肌瘤剔除或子宫切除术的患者中,未被怀疑的子宫肉瘤和平滑肌肉瘤患病率高于既往报道,这加大了放射科医生区分两者的压力。
要点
- MRI需鉴别典型与非典型平滑肌瘤与平滑肌肉瘤,以支持治疗前决策。
- 美国FDA审查发现推定良性平滑肌瘤手术中未被怀疑的子宫肉瘤和平滑肌肉瘤患病率高于既往报道。
- 腹腔镜旋切器辅助子宫切除术后发生播散性平滑肌肉瘤病例引发媒体关注。
核心结论
- 放射科医生面临更大压力,需在治疗前利用MRI区分平滑肌肉瘤与良性平滑肌瘤。
研究设计与样本
- 综述,旨在提供子宫平滑肌瘤的流行病学、临床和经济影响背景,总结治疗潜在隐匿性平滑肌肉瘤的担忧,并综述典型与非典型平滑肌瘤的已知和新兴影像特征及与平滑肌肉瘤的鉴别方法。
临床应用与阅片要点
- 作者指出,放射科医生需在治疗前区分平滑肌肉瘤与平滑肌瘤的压力增加。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The purpose of this article is to provide background on the epidemiologic, clinical, and economic impact of uterine leiomyomas, summarize the concerns associated with treating women with potential occult leiomyosarcomas (LMSs), and review the known and emerging imaging features of typical and atypical leiomyomas and explain how to differentiate them from LMSs.
CONCLUSION: Surgical management of presumed benign uterine leiomyomas received popular media attention when a case of disseminated LMS occurred after laparoscopic power morcellator-assisted hysterectomy. A subsequent U.S. Food and Drug Administration review found a higher prevalence of unsuspected uterine sarcoma and LMS among patients undergoing myomectomy or hysterectomy for presumed benign leiomyomas than was previously reported. This heightened concern has led to increased pressure on radiologists to distinguish LMSs from leiomyomas.
引用
- DeMulder D, Ascher SM. Uterine Leiomyosarcoma: Can MRI Differentiate Leiomyosarcoma From Benign Leiomyoma Before Treatment? AJR Am J Roentgenol. 2018. PMID: 30354268. doi:10.2214/AJR.17.19234
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。